• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自闭症和智力迟钝儿童的高血清素血症及胺代谢产物

Hyperserotonemia and amine metabolites in autistic and retarded children.

作者信息

Hanley H G, Stahl S M, Freedman D X

出版信息

Arch Gen Psychiatry. 1977 May;34(5):521-31. doi: 10.1001/archpsyc.1977.01770170031002.

DOI:10.1001/archpsyc.1977.01770170031002
PMID:860890
Abstract

Mean whole blood serotonin (5-HT) levels were elevated in groups of autistic and severely retarded children. Eight of 27 (30%) individual autistic children, 13 of 25 (52%) severely retarded children, two of 23 (9%) mildly retarded children, and none of the control children had statistically significant blood 5-HT levels elevations (hyperserotonemia). Hyperserotonemic autistic children excreted more urinary 5-HT, 5-hydroxyindoleacetic acid (5-HIAA), tryptamine, and vanillylmandelic acid than did mildly retarded children with normal blood 5-HT levels. Rates of depletion and repletion of blood 5-HT levels in these two groups following reserpine therapy were identical. Oral tryptophan administration doubled urinary 5-HIAA excretion in both groups and raised urinary 5-HT levels in hyperserotonemic autistic children, but lowered urinary 5-HT in mildly retarded, normal blood 5-HT children. No clear mechanism for hyperserotonemia was found; the rationale for further investigations is discussed.

摘要

自闭症儿童组和重度智力迟钝儿童组的全血血清素(5-羟色胺,5-HT)平均水平升高。27名自闭症儿童中有8名(30%)、25名重度智力迟钝儿童中有13名(52%)、23名轻度智力迟钝儿童中有2名(9%),而对照组儿童中无一例血液5-HT水平有统计学意义的升高(高血清素血症)。与血液5-HT水平正常的轻度智力迟钝儿童相比,高血清素血症的自闭症儿童排泄出更多的尿5-HT、5-羟吲哚乙酸(5-HIAA)、色胺和香草扁桃酸。这两组在利血平治疗后血液5-HT水平的消耗和补充速率相同。口服色氨酸使两组的尿5-HIAA排泄量增加一倍,并使高血清素血症的自闭症儿童的尿5-HT水平升高,但使血液5-HT水平正常的轻度智力迟钝儿童的尿5-HT水平降低。未发现高血清素血症的确切机制;文中讨论了进一步研究的理论依据。

相似文献

1
Hyperserotonemia and amine metabolites in autistic and retarded children.自闭症和智力迟钝儿童的高血清素血症及胺代谢产物
Arch Gen Psychiatry. 1977 May;34(5):521-31. doi: 10.1001/archpsyc.1977.01770170031002.
2
Urinary excretion of 5-hydroxyindoleacetic acid, serotonin and 6-sulphatoxymelatonin in normoserotonemic and hyperserotonemic autistic individuals.尿中 5-羟吲哚乙酸、血清素和 6-硫酸褪黑素在正常血清素和高血清素自闭症个体中的排泄。
Neuropsychobiology. 2010;61(1):27-32. doi: 10.1159/000258640. Epub 2009 Nov 13.
3
Urinary 5-hydroxyindoleacetic acid and whole blood serotonin and tryptophan in autistic and normal subjects.自闭症患者与正常受试者的尿5-羟吲哚乙酸、全血血清素及色氨酸水平
Biol Psychiatry. 1987 Aug;22(8):933-40. doi: 10.1016/0006-3223(87)90002-3.
4
Urinary levels of biogenic amine metabolites in mentally retarded children.
J Ment Defic Res. 1988 Oct;32 ( Pt 5):419-24. doi: 10.1111/j.1365-2788.1988.tb01432.x.
5
Autistic children and their first-degree relatives: relationships between serotonin and norepinephrine levels and intelligence.自闭症儿童及其一级亲属:血清素和去甲肾上腺素水平与智力之间的关系。
J Neuropsychiatry Clin Neurosci. 1990 Summer;2(3):268-74. doi: 10.1176/jnp.2.3.268.
6
Monoamines (serotonin and catecholamines) and their derivatives in infantile autism: age-related changes and drug effects.单胺类物质(血清素和儿茶酚胺)及其衍生物与儿童自闭症:年龄相关变化及药物作用
Dev Med Child Neurol. 1992 Jul;34(7):593-603. doi: 10.1111/j.1469-8749.1992.tb11490.x.
7
Serotonin and autism: biochemical and molecular biology features.
Psychiatry Res. 1996 Nov 1;65(1):33-43. doi: 10.1016/0165-1781(96)02882-x.
8
Peripheral markers of serotonergic and noradrenergic function in post-pubertal, caucasian males with autistic disorder.
Neuropsychopharmacology. 2000 Mar;22(3):275-83. doi: 10.1016/S0893-133X(99)00131-1.
9
[Metabolism of serotonin in autism in children].[儿童自闭症中血清素的代谢]
Encephale. 1988 Nov-Dec;14(6):413-9.
10
Blood serotonin and free tryptophan concentration in autistic children.
Neuropsychobiology. 1984;11(1):22-7. doi: 10.1159/000118045.

引用本文的文献

1
Genome-wide DNA methylation profiles in the raphe nuclei of patients with autism spectrum disorder.自闭症谱系障碍患者中缝核的全基因组DNA甲基化图谱。
Psychiatry Clin Neurosci. 2025 Jul;79(7):415-424. doi: 10.1111/pcn.13830. Epub 2025 Apr 24.
2
Modulation of autism-associated serotonin transporters by palmitoylation: Insights into the molecular pathogenesis and targeted therapies for autism spectrum disorder.棕榈酰化对自闭症相关血清素转运体的调节作用:对自闭症谱系障碍分子发病机制及靶向治疗的见解
bioRxiv. 2025 Mar 13:2025.03.12.642908. doi: 10.1101/2025.03.12.642908.
3
A Systematic Review on Autism and Hyperserotonemia: State-of-the-Art, Limitations, and Future Directions.
关于自闭症与高血清素血症的系统评价:现状、局限性及未来方向
Brain Sci. 2024 May 10;14(5):481. doi: 10.3390/brainsci14050481.
4
Contribution of the serotonergic system to developmental brain abnormalities in autism spectrum disorder.5-羟色胺能系统对自闭症谱系障碍发育性脑异常的贡献。
Autism Res. 2024 Jul;17(7):1300-1321. doi: 10.1002/aur.3123. Epub 2024 Mar 18.
5
Maternal LPS Exposure Enhances the 5-HT Level in the Prefrontal Cortex of Autism-like Young Offspring.母体暴露于脂多糖会提高自闭症样幼年后代前额叶皮质中的5-羟色胺水平。
Brain Sci. 2023 Jun 15;13(6):958. doi: 10.3390/brainsci13060958.
6
The microbiota-gut-brain axis and neurodevelopmental disorders.微生物群-肠道-大脑轴与神经发育障碍。
Protein Cell. 2023 Oct 25;14(10):762-775. doi: 10.1093/procel/pwad026.
7
Intestinal Barrier Dysfunction and Microbiota-Gut-Brain Axis: Possible Implications in the Pathogenesis and Treatment of Autism Spectrum Disorder.肠道屏障功能障碍与肠道微生物群-脑轴:在自闭症谱系障碍发病机制和治疗中的可能意义。
Nutrients. 2023 Mar 27;15(7):1620. doi: 10.3390/nu15071620.
8
Treatment of Autism Spectrum Disorders by Mitochondrial-targeted Drug: Future of Neurological Diseases Therapeutics.线粒体靶向药物治疗自闭症谱系障碍:神经疾病治疗的未来。
Curr Neuropharmacol. 2023;21(5):1042-1064. doi: 10.2174/1570159X21666221121095618.
9
Association of NGF and Mitochondrial Respiration with Autism Spectrum Disorder.神经生长因子(NGF)与线粒体呼吸与自闭症谱系障碍的关联。
Int J Mol Sci. 2022 Oct 7;23(19):11917. doi: 10.3390/ijms231911917.
10
Molecular Mechanisms of New Bone Formation in Axial Spondyloarthritis.中轴型脊柱关节炎中新骨形成的分子机制
Mediterr J Rheumatol. 2022 Apr 15;33(Suppl 1):115-125. doi: 10.31138/mjr.33.1.115. eCollection 2022 Mar.